Origin and impact of multifocal growth in sporadic vs. hereditary medullary thyroid cancer

被引:3
|
作者
Machens, Andreas [1 ]
Lorenz, Kerstin [1 ]
Weber, Frank [2 ]
Dralle, Henning [1 ,2 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Med Fac, Dept Visceral Vasc & Endocrine Surg, Ernst-Grube-Str 40, D-06097 Halle, Germany
[2] Univ Duisburg Essen, Dept Gen Visceral & Transplantat Surg, Div Endocrine Surg, D-45122 Essen, Germany
来源
EJSO | 2024年 / 50卷 / 11期
关键词
Medullary thyroid carcinoma; RET proto-oncogene; Malignant progression; Tumor multifocality; Microscopic lymphatic invasion; Lymph node metastases;
D O I
10.1016/j.ejso.2024.108625
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Multifocal growth is characteristic of hereditary medullary thyroid cancer (MTC), whereas origin and impact of multifocal growth is enigmatic for sporadic MTC. To address this, 460 RET-negative patients with sporadic MTC, stratified by 1 (93.3 %), 2 (5.7 %) and 3 (1.1 %) thyroid tumor foci, were compared with 219 RET-positive patients with hereditary MTC, stratified by 1 (38.4 %), 2 (45.7 %), 3 (6.4 %), 4 (6.8 %) and >= 5 (2.7 %) thyroid tumor foci. For sporadic MTC, significant associations were identified with bilateral thyroid lobe involvement, microscopic lymphatic invasion, extrathyroid extension, node and distant metastases, number of node metastases, preoperative basal calcitonin level, and decreasing biochemical cure. For hereditary MTC, significant associations were limited to bilateral thyroid lobe involvement, largest thyroid tumor diameter, and preoperative basal calcitonin level. In sporadic MTC, multifocal growth is due to lymphatic invasion with frequent node metastases, whereas in hereditary MTC, it reflects malignant progression from C-cell hyperplasia to cancer.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] CD15 (LEUM1) IMMUNOREACTIVITY - PROGNOSTIC FACTOR FOR SPORADIC AND HEREDITARY MEDULLARY-THYROID CANCER
    LANGLE, F
    SOLIMAN, T
    NEUHOLD, N
    WIDHALM, G
    NIEDERLE, B
    ROKA, S
    KASERER, K
    BLAUENSTEINER, W
    DAM, K
    CLODI, M
    FLORES, J
    LOIDL, A
    SCHWARZLMULLER, B
    HUBER, E
    JAHL, G
    WAMPRECHTSHAMMER, K
    ROKA, R
    WORLD JOURNAL OF SURGERY, 1994, 18 (04) : 583 - 587
  • [32] Hereditary vs. sporadic prostate cancer: Differences in clinical data nd progression-free survival?
    Herkommer, K.
    Autenrieth, M.
    Merkle, M.
    Hautmann, R.
    Gschwend, J. E.
    Kron, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 248 - 248
  • [33] Genotype-specific progression of hereditary medullary thyroid cancer
    Machens, Andreas
    Lorenz, Kerstin
    Weber, Frank
    Dralle, Henning
    HUMAN MUTATION, 2018, 39 (06) : 860 - 869
  • [34] Genetic susceptibility to hereditary non-medullary thyroid cancer
    Kamani, Tina
    Charkhchi, Parsa
    Zahedi, Afshan
    Akbari, Mohammad R.
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2022, 20 (01)
  • [35] SCREENING FOR HEREDITARY MEDULLARY CANCER OF THE THYROID USING RFLP ANALYSIS
    LENOIR, G
    SOBOL, H
    NAROD, S
    CYTOGENETICS AND CELL GENETICS, 1989, 51 (1-4): : 1031 - 1032
  • [36] Genetic susceptibility to hereditary non-medullary thyroid cancer
    Tina Kamani
    Parsa Charkhchi
    Afshan Zahedi
    Mohammad R. Akbari
    Hereditary Cancer in Clinical Practice, 20
  • [37] Hereditary medullary thyroid cancer in Slovenia - genotype phenotype correlations
    Bergant, Damijan
    Hocevar, Marko
    Besic, Nikola
    Glavac, Damjan
    Korosec, Branka
    Caserman, Simon
    WIENER KLINISCHE WOCHENSCHRIFT, 2006, 118 (13-14) : 411 - 416
  • [38] Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma
    Ciampi, Raffaele
    Romei, Cristina
    Cosci, Barbara
    Vivaldi, Agnese
    Bottici, Valeria
    Renzini, Giulia
    Ugolini, Clara
    Tacito, Alessia
    Basolo, Fulvio
    Pinchera, Aldo
    Elisei, Rossella
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 348 (01) : 176 - 182
  • [39] CLINICAL CHARACTERISTICS DISTINGUISHING HEREDITARY FROM SPORADIC MEDULLARY-THYROID CARCINOMA - TREATMENT IMPLICATIONS
    BLOCK, MA
    JACKSON, CE
    GREENAWALD, KA
    YOTT, JB
    TASHJIAN, AH
    ARCHIVES OF SURGERY, 1980, 115 (02) : 142 - 148
  • [40] RET PROTOONCOGENE MUTATIONS IN INHERITED AND SPORADIC MEDULLARY-THYROID CANCER
    BLAUGRUND, JE
    JOHNS, MM
    EBY, YJ
    BALL, DW
    BAYLIN, SB
    HRUBAN, RH
    SIDRANSKY, D
    HUMAN MOLECULAR GENETICS, 1994, 3 (10) : 1895 - 1897